Teleflex Incorporated (NYSE:TFX) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP reduced its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 30.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 5,256 shares of the medical technology company’s stock after selling 2,330 shares during the period. Bridgewater Associates LP’s holdings in Teleflex were worth $935,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Headlands Technologies LLC bought a new stake in shares of Teleflex in the 4th quarter worth about $29,000. Avior Wealth Management LLC raised its stake in Teleflex by 81.2% during the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company’s stock valued at $50,000 after buying an additional 125 shares in the last quarter. IFP Advisors Inc lifted its holdings in Teleflex by 238.5% during the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after buying an additional 217 shares during the last quarter. Exchange Traded Concepts LLC lifted its holdings in Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock worth $61,000 after buying an additional 94 shares during the last quarter. Finally, R Squared Ltd acquired a new position in shares of Teleflex in the 4th quarter worth approximately $64,000. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Wells Fargo & Company reduced their price objective on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Truist Financial decreased their price target on shares of Teleflex from $149.00 to $140.00 and set a “hold” rating for the company in a report on Friday, April 11th. Morgan Stanley dropped their price objective on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 5th. Raymond James downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Finally, StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $169.63.

Teleflex Stock Up 1.1 %

TFX opened at $129.57 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 12 month low of $124.66 and a 12 month high of $249.91. The stock’s 50 day moving average price is $143.68 and its 200 day moving average price is $177.96. The stock has a market cap of $6.01 billion, a P/E ratio of 25.76, a P/E/G ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.05%. Teleflex’s dividend payout ratio is presently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.